Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-16-014930
Filing Date
2016-08-11
Accepted
2016-08-11 16:07:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B5 a2229450z424b5.htm 424B5 230309
  Complete submission text file 0001047469-16-014930.txt   231332
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-212382 | Film No.: 161824637
SIC: 2834 Pharmaceutical Preparations